Anti-Apolipoprotein A V antibody - N-terminal (ab71265)


  • Product name
    Anti-Apolipoprotein A V antibody - N-terminal
    See all Apolipoprotein A V primary antibodies
  • Description
    Rabbit polyclonal to Apolipoprotein A V - N-terminal
  • Tested applications
    Suitable for: ELISA, WB, IHC-Pmore details
  • Species reactivity
    Reacts with: Human
  • Immunogen

    Synthetic peptide from the N-terminal region of human Apolipoprotein A V conjugated to KLH

  • Positive control
    • HL60 cell line lysate.



Our Abpromise guarantee covers the use of ab71265 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
ELISA 1/1000.
WB 1/50 - 1/100. Detects a band of approximately 41 kDa (predicted molecular weight: 41 kDa).
IHC-P 1/10 - 1/50.


  • Function
    Minor apolipoprotein mainly associated with HDL and to a lesser extent with VLDL. May also be associated with chylomicrons. Important determinant of plasma triglyceride (TG) levels by both being a potent stimulator of apo-CII lipoprotein lipase (LPL) TG hydrolysis and a inhibitor of the hepatic VLDL-TG production rate (without affecting the VLDL-apoB production rate) (By similarity). Activates poorly lecithin:cholesterol acyltransferase (LCAT) and does not enhance efflux of cholesterol from macrophages.
  • Tissue specificity
    Liver and plasma.
  • Involvement in disease
    Defects in APOA5 are a cause of susceptibility to familial hypertriglyceridemia (FHTR)[MIM:145750].mFamilial hypertriglyceridemia is a common inherited disorder in which the concentration of very low density lipoprotein (VLDL) is elevated in the plasma. This leads to increased risk of heart disease, obesity, and pancreatitis.
    Defects in APOA5 are a cause of hyperlipoproteinemia type 5 (HLPP5) [MIM:144650]. HLPP5 is characterized by increased amounts of chylomicrons and very low density lipoprotein (VLDL) and decreased low density lipoprotein (LDL) and high density lipoprotein (HDL) in the plasma after a fast. Numerous conditions cause this phenotype, including insulin-dependent diabetes mellitus, contraceptive steroids, alcohol abuse, and glycogen storage disease type 1A (GSD1A) [MIM:232200].
  • Sequence similarities
    Belongs to the apolipoprotein A1/A4/E family.
  • Post-translational
    Phosphorylation sites are present in the extracelllular medium.
  • Cellular localization
  • Information by UniProt
  • Database links
  • Alternative names
    • Apo-AV antibody
    • ApoA-V antibody
    • Apoa5 antibody
    • APOA5_HUMAN antibody
    • ApoAV antibody
    • Apolipoprotein A-V antibody
    • Apolipoprotein A5 antibody
    • RAP3 antibody
    • Regeneration associated protein 3 antibody
    • Regeneration-associated protein 3 antibody
    see all

Anti-Apolipoprotein A V antibody - N-terminal images

  • Anti-Apolipoprotein A V antibody - N-terminal (ab71265) at 1/60 dilution + HL60 cell line lysate at 35 µg

    Predicted band size : 41 kDa
    Observed band size : 41 kDa
    Additional bands at : 110 kDa,28 kDa,52 kDa,65 kDa,80 kDa. We are unsure as to the identity of these extra bands.
  • ab71265 at 1/50 dilution staining Apolipoprotein - A - V N - terminal in human hepatocarcinoma tissue section by Immunohistochemistry (Formalin/ PFA fixed paraffin-embedded sections). A peroxidase conjugated secondary antibody was used followed by DAB staining.

References for Anti-Apolipoprotein A V antibody - N-terminal (ab71265)

ab71265 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab71265.
Please use the links above to contact us or submit feedback about this product.


Sign up